SOAT1 as a metabolic immune checkpoint: Reprogramming lipid metabolism to inflame hepatocellular carcinoma

Hepatocellular carcinoma is characterized by profound metabolic reprogramming and immune evasion, yet the mechanisms by which lipid metabolism intersects with antitumor immunity remain incompletely understood. Recent work by Ma et al. identifies sterol O-acyltransferase 1 (SOAT1) as a metabolic immune checkpoint in HCC. Beyond its canonical role in cholesterol esterification, SOAT1 inhibition disrupts lipid homeostasis, triggering lipotoxic stress, reactive oxygen species production, and endoplasmic reticulum stress that converge on NF-κB activation. This metabolic-inflammatory cascade drives chemokine secretion, recruits antigen-presenting cells and cytotoxic T cells, and converts immunologically “cold” tumors into inflamed ones. Importantly, pharmacological SOAT1 inhibition synergizes with PD-1 blockade, highlighting a tractable strategy to reprogram the tumor microenvironment and enhance immunotherapy efficacy in hepatocellular carcinoma.